메뉴 건너뛰기




Volumn 20, Issue 2, 2009, Pages 200-203

Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BEVACIZUMAB; BIOLOGICAL MARKER; CALCIUM ANTAGONIST; DIURETIC AGENT; FIBRIN; FLUOROURACIL; IRINOTECAN; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; SORAFENIB; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

EID: 60549113344     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp018     Document Type: Editorial
Times cited : (29)

References (38)
  • 1
    • 33645451829 scopus 로고    scopus 로고
    • Angiogenesis inhibitors and hypertension: An emerging issue
    • Sica DA. Angiogenesis inhibitors and hypertension: An emerging issue. J Clin Oncol 2006; 24: 1329-1331.
    • (2006) J Clin Oncol , vol.24 , pp. 1329-1331
    • Sica, D.A.1
  • 2
    • 38049092600 scopus 로고    scopus 로고
    • Home blood-pressure monitoring in patients receiving sunitinib
    • Azizi M, Chedid A, Oudard S. Home blood-pressure monitoring in patients receiving sunitinib. N Engl J Med 2008; 358: 95-97.
    • (2008) N Engl J Med , vol.358 , pp. 95-97
    • Azizi, M.1    Chedid, A.2    Oudard, S.3
  • 3
    • 60549118166 scopus 로고    scopus 로고
    • Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab
    • Scartozzi M, Galizia E, Chiorrini S et al. Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab. Ann Oncol 2009; 20: 227-230.
    • (2009) Ann Oncol , vol.20 , pp. 227-230
    • Scartozzi, M.1    Galizia, E.2    Chiorrini, S.3
  • 4
    • 0030890708 scopus 로고    scopus 로고
    • Manipulating angiogenesis: From basic science to the bedside
    • Pepper MS. Manipulating angiogenesis: From basic science to the bedside. Arterioscler Thromb Vasc Biol 1997; 17: 605-619.
    • (1997) Arterioscler Thromb Vasc Biol , vol.17 , pp. 605-619
    • Pepper, M.S.1
  • 5
    • 0030576517 scopus 로고    scopus 로고
    • Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
    • Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364.
    • (1996) Cell , vol.86 , pp. 353-364
    • Hanahan, D.1    Folkman, J.2
  • 6
    • 85013312416 scopus 로고
    • Tumor angiogenesis: Therapeutic implications
    • Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 285: 1182-1186.
    • (1971) N Engl J Med , vol.285 , pp. 1182-1186
    • Folkman, J.1
  • 7
    • 0024384470 scopus 로고
    • Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
    • Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-855.
    • (1989) Biochem Biophys Res Commun , vol.161 , pp. 851-855
    • Ferrara, N.1    Henzel, W.J.2
  • 8
    • 0024816246 scopus 로고
    • Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells
    • Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J 1989; 8: 3801-3807.
    • (1989) EMBO J , vol.8 , pp. 3801-3807
    • Plouet, J.1    Schilling, J.2    Gospodarowicz, D.3
  • 9
    • 0024818355 scopus 로고
    • Vascular endothelial growth factor is a secreted angiogenic mitogen
    • Leung DW, Cachianes G, Kuang WJ et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1313.
    • (1989) Science , vol.246 , pp. 1306-1313
    • Leung, D.W.1    Cachianes, G.2    Kuang, W.J.3
  • 10
    • 0025275078 scopus 로고
    • Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor
    • Conn G, Bayne ML, Soderman DD et al. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci U S A 1990; 82: 2628-2632.
    • (1990) Proc Natl Acad Sci U S A , vol.82 , pp. 2628-2632
    • Conn, G.1    Bayne, M.L.2    Soderman, D.D.3
  • 11
    • 3042548695 scopus 로고    scopus 로고
    • Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts
    • Inai T, Mancuso M, Hashizume H et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 2004; 165: 35-52.
    • (2004) Am J Pathol , vol.165 , pp. 35-52
    • Inai, T.1    Mancuso, M.2    Hashizume, H.3
  • 12
    • 0038443099 scopus 로고    scopus 로고
    • Anti-angiogenic therapy: Rationale, challenges and clinical studies
    • Longo R, Sarmiento R, Fanelli M et al. Anti-angiogenic therapy: rationale, challenges and clinical studies. Angiogenesis 2004; 5: 237-256.
    • (2004) Angiogenesis , vol.5 , pp. 237-256
    • Longo, R.1    Sarmiento, R.2    Fanelli, M.3
  • 13
    • 0031471950 scopus 로고    scopus 로고
    • Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium
    • Horowitz JR, Rivard A, van der Zee R et al. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol 1997; 17: 2793-2800.
    • (1997) Arterioscler Thromb Vasc Biol , vol.17 , pp. 2793-2800
    • Horowitz, J.R.1    Rivard, A.2    van der Zee, R.3
  • 14
    • 32944474182 scopus 로고    scopus 로고
    • VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
    • Kamba T, Tam BY, Hashizume H et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290: H560-H576.
    • Am J Physiol Heart Circ Physiol , vol.290
    • Kamba, T.1    Tam, B.Y.2    Hashizume, H.3
  • 15
    • 32944466693 scopus 로고    scopus 로고
    • Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling
    • Baffert F, Le T, Sennino B et al. Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 2006; 290: H547-H559.
    • (2006) Am J Physiol Heart Circ Physiol , vol.290
    • Baffert, F.1    Le, T.2    Sennino, B.3
  • 16
    • 34250365240 scopus 로고    scopus 로고
    • Mechanisms of adverse effects of anti-VEGF therapy for cancer
    • Kamba T, McDonald DM. Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 2007; 96: 1788-1795.
    • (2007) Br J Cancer , vol.96 , pp. 1788-1795
    • Kamba, T.1    McDonald, D.M.2
  • 17
    • 43049085201 scopus 로고    scopus 로고
    • Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation
    • Mourad JJ, des Guetz G, Debbabi H, Levy BI. Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation. Ann Oncol 2008; 19: 927-934.
    • (2008) Ann Oncol , vol.19 , pp. 927-934
    • Mourad, J.J.1    des Guetz, G.2    Debbabi, H.3    Levy, B.I.4
  • 18
    • 50349101200 scopus 로고    scopus 로고
    • Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor
    • Steeghs N, Gelderblom H, Roodt JO et al. Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor. Clin Cancer Res 2008; 14: 3470-3476.
    • (2008) Clin Cancer Res , vol.14 , pp. 3470-3476
    • Steeghs, N.1    Gelderblom, H.2    Roodt, J.O.3
  • 20
    • 33751076238 scopus 로고    scopus 로고
    • Hypertension: A disease of the microcirculation?
    • Feihl F, Liaudet L, Waeber B, Levy BI. Hypertension: A disease of the microcirculation? Hypertension 2006; 48: 1012-1017.
    • (2006) Hypertension , vol.48 , pp. 1012-1017
    • Feihl, F.1    Liaudet, L.2    Waeber, B.3    Levy, B.I.4
  • 21
    • 0001128050 scopus 로고
    • Conjunctival vessels
    • Ruedemann AD. Conjunctival vessels. J Am Med Assoc 1933; 101: 1477-1481.
    • (1933) J Am Med Assoc , vol.101 , pp. 1477-1481
    • Ruedemann, A.D.1
  • 22
    • 0021021737 scopus 로고
    • Attenuation of the microcirculation in young patients with high-output borderline hypertension
    • Sullivan JM, Prewitt RL, Josephs JA. Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension 1983; 5: 844-851.
    • (1983) Hypertension , vol.5 , pp. 844-851
    • Sullivan, J.M.1    Prewitt, R.L.2    Josephs, J.A.3
  • 23
    • 0035569049 scopus 로고    scopus 로고
    • Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction
    • Serne EH, Gans ROB, ter Maaten JC et al. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001; 38: 238-242.
    • (2001) Hypertension , vol.38 , pp. 238-242
    • Serne, E.H.1    Gans, R.O.B.2    ter Maaten, J.C.3
  • 24
    • 0032890953 scopus 로고    scopus 로고
    • Structural skin capillary rarefaction in essential hypertension
    • Antonios TFT, Singer DRJ, Markandu ND et al. Structural skin capillary rarefaction in essential hypertension. Hypertension 1999; 33: 998-1001.
    • (1999) Hypertension , vol.33 , pp. 998-1001
    • Antonios, T.F.T.1    Singer, D.R.J.2    Markandu, N.D.3
  • 25
    • 0028952831 scopus 로고
    • Capillary rarefaction in the forearm skin in essential hypertension
    • Prasad A, Dunnill GS, Mortimer PS, MacGregor GA. Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens 1995; 13: 265-268.
    • (1995) J Hypertens , vol.13 , pp. 265-268
    • Prasad, A.1    Dunnill, G.S.2    Mortimer, P.S.3    MacGregor, G.A.4
  • 26
    • 33646118227 scopus 로고    scopus 로고
    • Increased skin capillary density in treated essential hypertensive patients
    • Debbabi H, Uzan L, Mourad JJ et al. Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens 2006; 19: 477-483.
    • (2006) Am J Hypertens , vol.19 , pp. 477-483
    • Debbabi, H.1    Uzan, L.2    Mourad, J.J.3
  • 27
    • 0030949484 scopus 로고    scopus 로고
    • Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure
    • Noon JP, Walker BR, Webb DJ et al. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99: 1873-1879.
    • (1997) J Clin Invest , vol.99 , pp. 1873-1879
    • Noon, J.P.1    Walker, B.R.2    Webb, D.J.3
  • 28
    • 0032716059 scopus 로고    scopus 로고
    • Impaired wound healing and angiogenesis in eNOS-deficient mice
    • Lee PC, Salyapongse AN, Bragdon GA et al. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 1999; 277: H1600-H1608.
    • (1999) Am J Physiol , vol.277
    • Lee, P.C.1    Salyapongse, A.N.2    Bragdon, G.A.3
  • 29
    • 0343851651 scopus 로고    scopus 로고
    • Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells
    • Dulak J, Jozkowicz A, Dembinska-Kiec A et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20: 659-666.
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , pp. 659-666
    • Dulak, J.1    Jozkowicz, A.2    Dembinska-Kiec, A.3
  • 30
    • 0035988521 scopus 로고    scopus 로고
    • Inhibition of NO biosynthesis, but not elevated blood pressure, reduces angiogenesis in rat models of secondary hypertension
    • Kiefer FN, Misteli H, Kalak N et al. Inhibition of NO biosynthesis, but not elevated blood pressure, reduces angiogenesis in rat models of secondary hypertension. Blood Press 2002; 11: 116-124.
    • (2002) Blood Press , vol.11 , pp. 116-124
    • Kiefer, F.N.1    Misteli, H.2    Kalak, N.3
  • 31
    • 0025732941 scopus 로고
    • Penetration of the systemic blood pressure into the microvasculature of rat skeletal muscle
    • DeLano FA, Schmid-Schonbein GW, Skalak TC, Zweifach BW. Penetration of the systemic blood pressure into the microvasculature of rat skeletal muscle. Microvasc Res 1991; 41: 92-110.
    • (1991) Microvasc Res , vol.41 , pp. 92-110
    • DeLano, F.A.1    Schmid-Schonbein, G.W.2    Skalak, T.C.3    Zweifach, B.W.4
  • 32
    • 0024557970 scopus 로고
    • Microvascular rarefaction and tissue vascular resistance in hypertension
    • Greene AS, Tonellato PJ, Lui J et al. Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol 1989; 256: H126-H131.
    • (1989) Am J Physiol , vol.256
    • Greene, A.S.1    Tonellato, P.J.2    Lui, J.3
  • 33
    • 38549085315 scopus 로고    scopus 로고
    • Incidence and risk if hypertension with sorafenib in patients with cancer: A systemic review and metaanalysis
    • Wu S, Chen JJ, Kudelka A et al. Incidence and risk if hypertension with sorafenib in patients with cancer: A systemic review and metaanalysis. Lancet Oncol 2008; 9: 117-123.
    • (2008) Lancet Oncol , vol.9 , pp. 117-123
    • Wu, S.1    Chen, J.J.2    Kudelka, A.3
  • 34
    • 0025234906 scopus 로고
    • Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
    • MacMahon S, Peto R, Cutler J et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
    • (1990) Lancet , vol.335 , pp. 765-774
    • MacMahon, S.1    Peto, R.2    Cutler, J.3
  • 35
    • 0037079309 scopus 로고    scopus 로고
    • Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
    • Prospective Studies Collaboration
    • Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
    • (2002) Lancet , vol.360 , pp. 1903-1913
  • 36
    • 34250350040 scopus 로고    scopus 로고
    • Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
    • 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
    • (2007) J Hypertens 2007 , vol.25 , pp. 1105-1187
  • 37
    • 0346171341 scopus 로고    scopus 로고
    • Framingham-based tools to calculate the global risk of coronary heart disease: A systematic review of tools for clinicians
    • Sheridan S, Pignone M, Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease: A systematic review of tools for clinicians. J Gen Intern Med 2003; 18: 1039-1052.
    • (2003) J Gen Intern Med , vol.18 , pp. 1039-1052
    • Sheridan, S.1    Pignone, M.2    Mulrow, C.3
  • 38
    • 57049125046 scopus 로고    scopus 로고
    • Vascular and renal effects of anti-angiogenic therapy
    • Halimi JM, Azizi M, Bobrie G et al. Vascular and renal effects of anti-angiogenic therapy. Nephrol Ther 2008; 4: 602-615.
    • (2008) Nephrol Ther , vol.4 , pp. 602-615
    • Halimi, J.M.1    Azizi, M.2    Bobrie, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.